Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis
S. A. Harrison, S. R. Marri, N. Chalasani, R. Kohli, W. Aronstein, G. A. Thompson, W. Irish, M. V. Miles, S. A. Xanthakos, E. Lawitz, M. Noureddin, T. D. Schiano, M. Siddiqui, A. Sanyal, B. A. Neuschwander-Tetri, P. G. Traber
Research output: Contribution to journal › Article › peer-review
139Scopus
citations
Fingerprint
Dive into the research topics of 'Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis'. Together they form a unique fingerprint.